Luzitin
PrivateLast Round
Growth Equity
Dec 19, 2023
Total Funding Raised
$32.84M
Company Overview
Luzitin is a drug discovery company that develops innovative photosensitizing compounds intended for photodynamic therapy and photo diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luzitin Comparables
Compare Luzitin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| biolitec Holding GmbH & Co KG | 80% | |
| ImPact Biotech | 78% | |
| Theralase Technologies Inc. | 78% |
Luzitin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 19, 2023 | ||||
| Seed | Oct 7, 2010 |
Key People
Founding team and executive leadership
Luzitin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InovCapital | Seed |
| C2 Capital Partners | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 108% MoM, reaching 9.3K.
- Jul 2, 2025
Monthly visitors grew 72% MoM, reaching 5K.
Luzitin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Luzitin's valuation, stock price, and market status.
Is Luzitin a public or private company?
Luzitin is a private company.
What is the current stock price of Luzitin?
Luzitin is a private company with no public stock price. No recent secondary market data is available.
How much is Luzitin worth (valuation)?
Valuation information for Luzitin is not publicly available.
Can I buy Luzitin stock?
Luzitin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Luzitin's last funding round?
Luzitin's most recent funding round was Growth Equity on December 19, 2023.
Who are the main investors in Luzitin?
Key investors in Luzitin include C2 Capital Partners.
Will Luzitin IPO soon?
No public IPO plans have been announced for Luzitin.
How can I track Luzitin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luzitin's secondary market activity and sign up for updates.